Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay

Xueying Fan(Leiden University Medical Center), Tao Su(Macau University of Science and Technology)
Journal of Translational Medicine
April 16, 2023
Cited by 15


Related Papers